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Innovating in Health Care:  
The Contextual Specificity of Capital 
ABSTRACT 
Prior research suggests that innovation process effectiveness (IPE) – the degree to which an 
organization proficiently coordinates resources and activities for innovation – is a key 
contributor to organizational innovativeness, and ultimately organizational success. Despite the 
pivotal role of IPE, little research has focused on the factors that facilitate IPE. I propose that IPE 
depends on organizations’ ability to access needed knowledge. Specifically, I hypothesize that 
IPE is related to organizational access to human capital (i.e., knowledge embedded in workers) 
and organizational capital (i.e., knowledge embedded in structures), with the relative impact of 
each capital differing between health care and other innovative industries due to industry-based 
differences in knowledge properties. My study of 221 organizations confirmed that access to 
capital predicts IPE, with the relevant capital differing by industry. In the health care industry, 
only human capital was positively associated with IPE, as measured by its three indicators: 
combinative capability, process efficiency, and output quality. In contrast, in other innovative 
industries, both human capital and organizational capital were associated with IPE. In these non-
health care industries, access to both capitals predicted combinative capability and efficiency, 
both of which mediated the relationship between access to capital and output quality. Only 
combinative capability mediated the relationship between human capital and output quality in 
health care. These results suggest that access to knowledge resources plays a significant role in 
IPE, but the impact of particular resources is context-specific.  
Key words: Knowledge repositories, innovation process effectiveness, contextual specificity, 
health care 
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1. INTRODUCTION 
Organizations across industries rely on innovation as a source of growth, cost reduction, and 
quality improvement (Teece 2007). A robust literature covering more than 200 studies suggests 
that innovation success depends on the effectiveness of organizations’ innovation process, that is, 
how proficiently organizations coordinate their resources and activities for idea development and 
implementation (Evanschitzky et al. 2012). Despite the importance of innovation process 
effectiveness (IPE) for innovation and organizational success, the factors that foster IPE have 
received little attention, leaving managers with limited guidance about how to improve IPE and 
leaving ambiguity in the organizational literature about a key contributor to innovation. 
Recognizing this gap, scholars have issued calls for theoretical development and empirical 
investigation of IPE (Lee et al. 2011). 
            This thesis seeks to answer the calls and investigates the role of knowledge resources in 
IPE. Specifically, I examine the effect on IPE of knowledge repositories within organizations. I 
focus on knowledge repositories because research indicates that creative enterprises such as 
innovation hinge on the integration and application of  knowledge (Subramaniam and Youndt 
2005). Building from this observation, I presume that access to relevant knowledge is a 
preceding necessity. Stored within knowledge repositories is knowledge about past and current 
organizational practices, their outcomes, and new ideas for improving performance (Walsh and 
Ungson 1991). In this work, I focus on the effect of access to two core knowledge repositories 
(Argote and Miron-Spektor 2011): organizational members (human capital) and organizational 
tasks, structures, tools, and routines (organizational capital). I focus on these two, as opposed to 
an extended suite of knowledge repositories, because they are subject to management 
intervention and I hope to inform industry practices in addition to theory. 
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There are several features of this research that are notable. First, it provides insight on 
how knowledge repositories relate to the innovation process. Prior work has emphasized the 
relationship between knowledge repositories and innovation outcomes (e.g., Ahuja (2000); 
Subramaniam and Venkatraman (2001)), without directly addressing the process by which 
knowledge repositories are related to outcomes. Second, this research provides a nuanced 
understanding of IPE as it examines the relationship between knowledge repositories and each of 
the criteria by which performance with respect to IPE is judged: increased combinative 
capability, process efficiency, and output quality (Brettel et al. 2012). Although prior work 
identified these criteria, it has not considered them individually nor potential relationships 
between them, which this work does. Last, but not least, this work addresses the question of 
whether the effect of access to knowledge repositories varies in industries with different features 
by comparing the effects in health care versus other innovative industries, using data from 221 
organizations in the United States (US) and the United Kingdom (UK).  
I separately examine health care because both scholars and practitioners have argued that 
health care is fundamentally different from other industries because it focuses on human life (and 
death) and must contend with the extreme form of challenges faced by other industries (e.g., 
customer/patient variability, knowledge intensity, etc.) (McCreary 2010; Ramanujam and 
Rousseau 2006). Additionally, I was compelled to examine IPE in health care separately 
because, although there are some organizations within health care that are heralded for their IPE 
(e.g., Gilead Sciences (Lubkeman 2010), Kaiser Permanente (McCreary 2010)), many, if not 
most, struggle with IPE. The top 20 pharmaceutical firms alone lost 30% of their market 
capitalization ($720 billion) from 2000 to 2010 as investors lost confidence in their competency 
to bring innovative products efficiently to market (Tollman et al. 2011). The difficulty with IPE 
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is not limited to pharmaceutical firms. The health care delivery sector (i.e., hospitals, medical 
groups, etc.) has also struggled with process-rooted challenges, like innovation implementation 
failures, which have resulted in less than expected quality improvement from innovation 
adoption (Nembhard et al. 2009). This is of particular concern because quality problems are 
widespread, resulting in nearly 100,000 preventable deaths annually in the US alone (Institute of 
Medicine 1999). Through this thesis, I aim to provide theoretically-derived, empirically-
evaluated insight on contributors to IPE in health care versus other industries. The results show 
there are differences between industries. 
 
2. ACCESS TO KNOWLEDGE REPOSITORIES AS A FACILITATOR OF IPE 
2.1. Access to Human Capital as a Facilitator of IPE across Industries 
According to scholars (e.g., Brettel et al. (2012)), IPE exists when the innovation process results 
in increased combinative capability, process efficiency, and high quality output. Combinative 
capability is the ability to generate new applications and concepts from existing knowledge. 
Efficiency exists when the organization's time to project completion and realized budget satisfies 
or exceeds expectations. A high quality output from an innovation process is an idea that is 
valued by potential customers. Reflecting these three criteria, IPE captures how proficiently an 
organization coordinates its activities in support of innovation creation, irrespective of whether 
the benefits of the innovation are realized. Thus, it differs from innovation effectiveness, which 
assesses the realization of the intended benefits of a given innovation (Klein et al. 2001).  
 I contend that the availability of human capital (Schultz 1961; Subramaniam and Youndt 
2005) – the knowledge, skills, and abilities residing within an organization’s workers – plays a 
significant role in facilitating all aspects of IPE. Workers have a unique capacity to interpret, 
evaluate, integrate, and create knowledge (March 1991). Furthermore, they are able to absorb 
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explicit as well as tacit and complex knowledge (Ferdows 2006). These abilities, rooted in 
human cognition (Kang et al. 2007), make it likely that access to human capital facilitates 
organizations’ combinative capability. Combinative capability, as noted above, is manifest in the 
creation of new applications from existing knowledge.  Cohen and Levinthal (1990) showed that 
the ability to recognize the potential value of knowledge, which is necessary for developing new 
applications, depends on the knowledge’s relationship to other knowledge already possessed. 
When workers possess related knowledge, they are better able to absorb and integrate 
knowledge, and presumably to combine it for new applications in future endeavors. Thus, the 
greater knowledge and expertise embedded in workers, the greater combinative capability of the 
organization should be. I expect this partly to be due to cognitive facility and partly due to the 
richness in information sharing that occurs when greater worker expertise exists (Lee et al 2011). 
Collins and Smith (2006) found that organizations that strategically chose their HR practices in 
order to have access to talented workers had staff that engaged in greater knowledge exchange 
and combination that led to valued products. Thus, I reason that human capital supports 
combinative capability.  
Human capital should also improve efficiency. Because information sharing quality is 
higher when human capital exists, I expect that knowledge is processed more efficiently. 
Efficiency is also likely to be greater because human capital enables rapid learning. Research on 
learning curves has found that organizational production accelerates as worker experience grows 
(Lapré and Nembhard 2010). This suggests increased efficiency due to learning by and 
embedded in workers.  According to learning theory, the knowledge and skill that workers 
acquire as they perform their tasks automatically results in their development of more efficient 
techniques for task completion. The notion of efficiency derived from learning embedded in 
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workers is based on studies of routine tasks, but should extend to innovative tasks as well as, 
which also require deliberate learning via experimentation (Thomke 1998), likely spurring more 
efficient processes. 
 Both process efficiency and combinative capability derived from human capital should 
increase the likelihood of a high quality output i.e., an idea that is valued by potential customers. 
Prior research suggests that most new ideas arise from the combination of existing principles or 
products (Smith et al. 2005). For example, the iPhone, a valued innovation in communications, 
was created when engineers at Apple combined the technology of more than 200 components 
suppliers with innumerable independent application providers (Reeves and Bernhardt 2011), 
suggesting the combinative capability of an organization can contribute to high quality output. 
The savvy integration of new knowledge in particular, which combinative capability enables, 
may help organizations to remain current and better positioned to formulate new ideas that 
respond to evolving customer needs or desires (Teece 2007).  
Expertise in process efficiency is also likely to foster high quality output. Pursuit of 
efficiency imposes an internal discipline for achieving goals subject to time and resource 
constraints. Such discipline induces an iterative decision process about what ideas hold the 
greatest potential value (Cooper et al. 1999), increasing the likelihood of selecting the best ideas 
and thus creating higher quality output. Extending from my propositions that both efficiency and 
combinative capability contribute to high quality output and that human capital enables 
efficiency and combinative capability, I further contend that the effect of human capital on 
output quality is mediated by combinative capability and efficiency. Summarizing, I posit: 
 
Hypothesis 1. Human capital is positively associated with (1a) combinative capability and (1b) 
efficiency, both of which mediate the relationship between human capital and (1c) output quality. 
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2.2. Access to Organizational Capital as a Facilitator of IPE across Industries  
Organizational capital is the institutionalized knowledge and codified experience residing in 
routines, tools, patents, licenses, databases, and systems (Youndt et al. 2004). I hypothesize that 
this form of capital is also positively associated with the elements of IPE, albeit for different 
reasons compared to human capital. Organizational capital likely enhances an organization's 
combinative capability by facilitating knowledge use (Cook and Brown 1999). Knowledge 
embedded in organizational capital has already been converted from tacit to explicit. The 
explicitness reduces causal ambiguity, thus, improving the comprehensibility of knowledge 
(Szulanski 1996) and ability to use it in future endeavors. Nonaka and Takeuchi (1995) found 
that, only upon understanding how a master baker kneads dough, codifying the motion as 
"twisting stretch" (p.105), was a design team able to create a superior kneading mechanism for 
bread-making machines. In its design, the team combined various existing kneading processes. 
Building on this finding, I propose that greater clarity of knowledge, which organizational capital 
facilitates, increases the ability to use and combine knowledge to create new applications.  
Likewise, the frame of reference provided by organizational capital should help with the 
evaluation of new against existing knowledge, thereby calibrating what information may be 
effectively combined in future endeavors (Kang and Snell 2009).  
 Organizational capital may also improve efficiency by virtue of providing easy to locate 
knowledge that is legitimized and instructive. The ease reduces the need for search, which 
increases efficiency. The fact that information stored in this repository has been legitimized and 
formulated in such a way as to be instructive (Brown and Duguid 1991) also means that the 
organization and its workers need not dedicate as much time to distilling and  interpreting 
knowledge during the innovation process as would be required for knowledge that had yet to be 
11 
 
codified. This promotes efficiency during the innovation process. Furthermore, having 
organizational capital may provide a benchmark for the setting of reasonable timelines and 
budgets, making achievement of them possible. Given my hypothesis that organizational capital 
is positively associated with efficiency and combinative capability, both of which I contend 
contribute to higher quality output as argued above, I propose that:   
 
 
Hypothesis 2. Organizational capital is positively associated with (2a) combinative capability 
and (2b) efficiency, both of which mediate the relationship between organizational capital and  
(2c) output quality. 
 
2.3. Relative Impact of Human and Organizational Capital on IPE in different Industries  
Scholars and practitioners have argued that industries can possess unique attributes that influence 
the relationship between organizational characteristics and outcomes, causing relationships to 
differ across contexts, an occurrence referred to as “contextual specificity” (Beckman and Sinha 
2005; Rousseau and Fried 2001). I contend that contextual specificity exists for the relationship 
between organizational access to knowledge repositories and IPE. In particular, I hypothesize 
that the impact of human and organizational capital differs for health care versus other industries 
due to differences in the knowledge utilized in health care.  
The health care industry consists of organizations that are broadly classified into two 
groups: health care delivery providers (hospitals, medical groups, etc.) and suppliers of health-
related technology (pharmaceutical corporations, biotechnology firms, etc.) (Burns 2005). The 
former provides preventative care and treatment to patients, while the latter supplies the 
technologies (e.g., drugs, diagnostic tests, etc.) used by the former to care for patients. In this 
thesis, I compare health care providers and suppliers with organizations in other innovative 
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industries such as electronics and network infrastructure.  
A key observation from prior research is that organizations and industries can vary in the 
types of knowledge upon which they draw and utilize (Cardinal 2001), an observation that is 
exemplified in the comparison of the health care industry to others. The rate of knowledge 
growth in health care is especially rapid, as indicated by the addition of over 700,000 new 
references to Medline per year (the bibliographic database for biomedical articles) (NIH 2012). 
Also reflecting its knowledge intensity, suppliers of health technology regularly dominate R&D 
investment rankings, accounting for 40% of global R&D expenditure by innovative corporations 
contributing to a high knowledge production function (Jaruzelski et al. 2012). This pace of 
knowledge growth places the health care industry at the extreme relative to other industries.  
 The nature of knowledge that dominates the industry also differentiates it from others. 
Scholars have observed that knowledge in health care has a significant tacit component (Berta 
and Baker 2004), not easily codified. Hence the emphasis on site visits to high-performing health 
care delivery providers to observe what is important for clinical excellence. Suppliers 
particularly grapple with tacit knowledge during product development. Identification of target 
molecules from myriad compounds is subject to irreducible uncertainty. Molecules are part of 
unique cellular mechanisms and even leading scientists may only have a partial understanding of 
molecule interaction in a given mechanism (Pisano 1996). As a result, drug development failure 
rates approach 90%, an extreme compared to other industries (Nature 2007).    
  The health care industry additionally wrestles with a high degree of specialization. Due 
to the volume of knowledge, health professionals have become increasingly specialized such that 
each now brings only a portion of the knowledge needed to effectively care for patients. The 
average patient in a hospital now receives care from more than 20 professionals (different types 
13 
 
of physicians, nurses, etc.) who must integrate their expertise to provide high-quality care 
(Bohmer and Knoop 2007). The increasing volume of knowledge, especially through the advent 
of biotechnology, has also caused suppliers to specialize (Nicholls-Nixon and Woo 2003). 
Specialized knowledge manifests in form of organizations focusing on specific therapeutic areas 
(e.g., biotechnology firms like Gilead Science on antiretroviral drugs) and on specific functions 
(e.g., contract research organizations like Covance on antibody development). Specialization has 
developed to a degree that contractual R&D partnerships are twice as prevalent in the 
pharmaceutical industry compared to any other industry (Hagedoorn 2002).     
Because of the industry’s knowledge properties – rapidly changing, highly tacit, and 
greatly specialized – I assert that human capital is more influential on IPE than organizational 
capital in health care. I expect this because organizational capital outdates more easily in 
environments with rapidly changing knowledge. The knowledge embedded in this repository 
becomes less relevant more quickly and there tends to be a delay in adding new knowledge to 
this repository especially when knowledge grows fast (Kang and Snell 2009). Thus, as the pace 
of knowledge increases, organizational capital’s ability to provide an effective frame of reference 
for the calibration of what information to combine and what efficiency goals to set diminishes, 
limiting its value for combinative capability and efficiency promotion. On the other hand, human 
capital retains and likely increases its value in the wake of fast-changing knowledge because of 
workers’ inherent ability to begin interpreting and integrating knowledge as soon as it is 
presented (March 1991). Their skill should make human capital a more effective facilitator of 
IPE than organizational capital in the rapidly evolving health care industry. 
Human capital further increases in value relative to organizational capital when the 
prevalence of tacit knowledge is considered. The increased incompleteness of the latter, which 
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does not readily store tacit knowledge, constrains its capacity to serve as a foundation for IPE 
when tacit knowledge is high. Consistent with this logic, in a review of over 400 pharmaceutical 
R&D projects, Hoang and Rothaermel (2010) found that performance of in-licensed projects was 
negative unless the licensee employed scientists with related drug development experience. In 
other words, firms failed to progress with the innovation process unless they drew upon human 
capital to process the tacit knowledge not embedded in the license. Hence, my theory that an 
industry high in tacit knowledge, like health care, benefits more from human capital.  
    The high knowledge specialization in health care lastly means that highly fragmented 
knowledge often needs to be integrated for task completion, whether it is a routine task or 
innovative task. The imperative for integration is reflected in recent innovations, which 
increasingly rely on reciprocal rather than sequential interactions between health professionals 
and scientists (Bohmer 2009). While all innovative organizations face the challenge of 
integrating knowledge, this challenge is magnified in health care by the volume of knowledge 
and specialization. Given that the integration of knowledge is conditional upon knowledge 
already possessed (Cohen and Levinthal 1990), and since skilled workers should possess more 
current and complete knowledge given the pace and tacitness of knowledge in health care, I 
expect human capital to play a more pivotal role in IPE rather than organizational capital: 
 
Hypothesis 3. In health care, human capital is more strongly associated with IPE – combinative 
capability (3a), efficiency (3b), and (3c) output quality – than organizational capital. 
 
3. RESEARCH METHODOLOGY 
3.1. Sample and Data Collection  
To empirically examine the relationship between the access to different knowledge repositories 
and IPE, I used survey data from a sample of organizations in a broad set of industries. To be 
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included in my sample, organizations had to satisfy two criteria. First, given our interest in 
innovative industries, organizations had to operate in innovative industries, indicated by greater 
than 45 percent of the industry engaged in innovation activity (Castellacci 2008).  Second, 
organizations had to have more than 50 employees because I sought to include organizations 
large enough for knowledge repositories to potentially serve a useful function (e.g., Bhattacharya 
et al. (2005)). Applying these criteria, relevant organizations operated in five industries: health 
care, computer/electronics manufacturing, specialized machinery manufacturing, network 
infrastructure services, and knowledge-intensive services. 
To study organizations in these industries, I used an approach routinely used in studies of 
knowledge repositories (e.g., Subramaniam and Youndt (2005)) and innovation processes (e.g., 
Poskela and Martinsuo (2009)): the key informant approach, surveying one executive (C–level 
executives, Presidents, and Directors) per firm. Recent meta–analytic correlations of subjective 
and archival measures showed that key informants are  highly reliable in innovation-intensive 
settings (Homburg et al. 2012). I identified potential informants using commercial databases in 
the UK and the US. Since these countries belong to the same cultural cluster (Ronen and Shenkar 
1985) and exhibit similarity in terms of IPE (Evanschitzky et al. 2012), this sampling strategy 
was applied to enlarge the pool of eligible key informants.    
 I invited 4,196 executives in the UK and US (1,922 UK; 2,274 US) to participate in the 
study via email in January 2012. Of the invitations sent, 2,479 were returned due to wrong email 
address and 74 were returned because the respondent left the company or replied as out of office. 
The remaining invitations (1,643) were not automatically returned, suggesting that they were 
received by the intended recipient. I received 253 survey responses, of which 32 had to be 
discarded due to missing data and/or respondent disqualification because of insufficient evidence 
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of key informant status. According to prior research (Homburg et al. 2012), an executive-level 
informant should hold a management position and/or have a high degree of involvement in 
strategic decision-making, which was determined based on responses to (a) "Please mark the 
answer that matches your job description best" (top, middle, line, or non-management) and (b) 
"Please indicate your level of involvement in corporate strategic activities" (5-point Likert scale: 
very high to very low involvement). I excluded all respondents not part of management, and 
discarded responses when informants indicated middle/ line management and low to very low 
involvement in strategic activities.  
 After disqualifications, I retained the data from 221 informant-respondents, for an 
effective response rate of 13.5%, similar to the rate for other surveys of top executives (i.e.,10–
12% (Hambrick et al. 1993)) and innovation processes (i.e., 15% (Poskela and Martinsuo 2009)). 
Informants had a very high degree of strategic involvement (≥ 70% of respondents), leadership 
positions (> 85% in top management positions), and a high level of experience in their position 
(≥ 90% with tenure exceeding 10 years). All organizations satisfied the 50–employee minimum 
criterion except for nine that reported fewer than 50 employees. Since these organizations 
initially satisfied the inclusion criterion per their database record and reported greater than 40 
employees in our survey, I retain them in my sample. Table 1 summarizes the respondent 
demographics, with each of the 221 informants providing information about one organization. 
Please insert Table 1 about here 
 
3.2. Measures  
Generalizable multi-item survey scales with seven-point Likert response format were used. To 
ascertain whether the measures captured the desired information and were psychometrically 
valid, I pilot-tested them with two groups prior to survey administration in my sample. First, I 
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fielded the survey with 59 MBA students. I then modified the survey based on the pilot-test 
results to improve the distinctiveness of the IPE dimensions and tested the refined measures with 
20 experts from industry and academia. For all measures (Appendix A), Cronbach's alpha (α), 
composite reliability (CR), and average variance extracted (AVE) indicated satisfactory 
reliability, convergent validity, and discriminant validity, based on recommended thresholds of 
0.7 for α and CR , and 0.5 for AVE (Hair et al. 2012).  
 Knowledge repositories. I measured human capital and organizational capital using 
Subramaniam and Youndt’s (2005) scales. I conducted a principal components factor analysis 
with varimax rotation and found support for the intended two-factor structure, with all but one 
item loading on its intended factor and both factors exhibiting eigenvalues greater than one. The 
one exceptional item was eliminated from the analyses. Confirmatory factor analysis (CFA) 
supported the two-factor specification (χ2/ degrees of freedom = 2.41, comparative fit index 
[CFI] = 0.94, incremental fit index [IFI] = 0.94, goodness-of-fit index [GFI] = 0.93). The first 
factor, indicating human capital, consisted of five items and measured the overall skill, expertise, 
and knowledge of employees (α = 0.89; CR = 0.92; AVE = 0.69). The second factor, indicating 
organizational capital, consisted of three items and assessed the extent to which the organization 
stored knowledge in structures such as databases and manuals (α = 0.60; CR = 0.79; AVE = 
0.55). Although this measure of organizational capital did not exceed the conventional threshold 
of 0.70 for α, it had a composite reliability of 0.79, which some regard as a more appropriate 
indicator of reliability because composite reliability provides a better assessment of internal 
consistency (Bagozzi and Youjae 1988; Hair et al. 2012) 
 Innovation process effectiveness. My measures of the three dimensions of IPE were 
adapted from Brettel et al. (2012). The first dimension, combinative capability, was assessed 
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using three items that asked the extent to which the innovation process enabled growth in 
expertise, capabilities, and ideas that might be applied (combined) in future endeavors (α = 0.91; 
CR = 0.94; AVE = 0.84). The second dimension, process efficiency, was assessed using three 
items that captured success in meeting schedule and budget goals (α = 0.87; CR = 0.92; AVE = 
0.80). Last, output quality was measured using three items that assessed perceived value, quality, 
and marketability of innovative ideas (α = 0.92; CR = 0.95; AVE = 0.86). A principal 
components factor analysis of all survey items using a varimax rotation confirmed the three 
factors, with all items loading on their intended factor and all factors exhibiting eigenvalues 
greater than one. CFA supported the three-factor specification (χ2/ degrees of freedom = 1.82, 
CFI = 0.98, IFI = 0.98, GFI = 0.94).  
 Control variables. I selected control variables based on three criteria recommended by 
(Becker 2005): (i) theory suggests that the variable might be correlated with the dependent 
variable, (ii) the variable might be correlated with a hypothesized independent variable, and (iii) 
the variable is not integral to the specified model, but theoretically important. Based on these 
criteria, I included organizational age (in years), R&D emphasis (measured by a seven-point 
Likert scale survey item asking respondents to indicate their level of agreement with this 
statement: "We put strong emphasis on R&D, innovation, and technological leadership"), prior 
performance (assessed by asking respondents to rank on a 1-5 scale their organization's 
performance compared to close competitors over the last three years in terms of profit level and 
market share), industry type (0 = manufacturing and 1 = service), and home country (0 = UK and 
1 = US) . These factors were selected because organizational age may influence the 
organization's ability to accumulate and embed knowledge in repositories over time (Walsh and 
Ungson 1991), while a firm's general emphasis on R&D could affect the effort to build 
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knowledge repositories that foster IPE (Subramaniam and Youndt 2005). Moreover, prior 
performance may be important because a positive trajectory frees resources for experimentation, 
which may improve innovation capabilities (Hill and Rothaermel 2003). Finally, industry type 
and home country were included because the innovation process in services may differ from that 
in manufacturing, or may differ by organizations' home country (Castellacci 2008). 
 
3.3. Analytic Methods  
I examined the proposed relationships with the organization as the unit of analysis and using 
structural equation models (SEM). Structural equation modeling allowed examining how one 
knowledge repository impacts output quality, accounting for potential mediation through 
combinative capability and efficiency, while holding the relationships between the other 
knowledge repository and the elements of IPE constant. I used partial least squares (PLS) models 
because such models are more appropriate than maximum likelihood covariance–based 
techniques when the sample includes less than 250 observations and the data are not normal 
(Reinartz et al. 2009). My data fit both of these criteria. The full sample included 221 
organizations and the subsamples for our cross-industry analysis were necessarily smaller (N=73 
health care organizations and N=148 organizations in other innovative industries). Additionally, 
the null hypothesis of data normality was rejected at the 1 percent level of significance for all 
indicators using a Shapiro–Wilk test. Kolmogorov–Smirnov tests confirmed these results. For 
data with these attributes, PLS SEM, which does not require any distributional assumptions, 
overcomes model identification issues and provides more reliable statistical results (Gefen et al. 
2011). Therefore, I used this variance-based SEM technique for my analyses, which were carried 
out with Smart PLS Version: 2.0.M3.  
I complemented the SEMs with additional mediation analysis that allowed assessing the 
20 
 
strengths of a particular mediation effect and comparing the effects of multiple mediators in a 
single model, applying Preacher and Hayes' (2008) procedure. To ensure that this additional 
analysis is based on the same data as the SEMs, I imported the standardized latent variables of 
my SEMs into SAS 9.3 prior to applying Preacher and Hayes' procedure. Given my non-normal 
data I used a nonparametric bootstrapping approach for this additional mediation analysis, 
interpreting the 95% bias corrected confidence intervals emerging from 1,000 bootstrap samples.  
 
4. RESULTS 
4.1. Evaluation of Measurement Models  
To assess the appropriateness of my PLS models, I followed Gefen et al. (2011) in calculating 
three metrics. First, I calculated the coefficient of determination R2, which indicates the 
explanatory power of models. The R2 values exceeded the threshold value of 0.19 for satisfactory 
power (0.207–0.649 for health care, 0.267–0.665 for non-health care, and 0.256–0.649 for the 
full sample) (Hair et al. 2012). Second, I estimated the Stone–Geisser–Criterion Q2 using a 
blindfolding procedure with omission distance of five. The Q2 values all exceeded zero (health 
care: 0.133–0.495; non-health care: 0.194–0.533; full sample: 0.180–0.529), suggesting that my 
models predict the latent variables well. Third, I computed the variance inflation factors (VIF) to 
examine multicollinearity among independent variables. The VIFs were less than 2 (health care: 
1.289–1.880; non-health care: 1.294–1.623; full sample: 1.277–1.663), hence much smaller than 
the threshold of 10 (Gefen et al. 2011). Last, to ensure that model fit was comparable across all 
models, I calculated models’ goodness-of-fit (GoF) as the geometric mean of the average 
communalities and the models' average R2 values (Hair et al. 2012). The GoF values were 0.514 
for health care, 0.545 for non-health care, and 0.535 for the full sample, suggesting 
comparability. Thus, summarizing across indicators, my models provided valid, reliable results. 
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4.2. Results of Models Examining the Capital-IPE Relationship  
Table 2 reports the means, standard deviations, and correlations of all variables. Table 3 presents 
the results of my structural equation models, examining the hypothesized relationships for health 
care (model 1), other innovative industries (model 2), and the full sample (model 3). Across 
models, human capital was positively and significantly associated with the first two indicators of 
IPE, combinative capability and efficiency, supporting Hypothesis 1a and 1b. Results for output 
quality and relationships between all variables, however, differed across models, that is, between 
industries. In the health care industry (model 1), only combinative capability was associated with 
output quality; it mediated the relationship between human capital and output quality. No direct 
or mediating effect of efficiency was found. Therefore, Hypothesis 1c is only partially supported 
in the health care industry. In contrast, in other industries (model 2), both combinative capability 
and efficiency were associated with output quality and mediated the relationship between human 
capital and output quality. These results support Hypothesis 1c in non-health care industries. 
Results of the all-industries model (not differentiating health care from other industries, model 3) 
mirrored those for the non-health model (model 2), which contained two-thirds of the sample.  
Please insert Tables 2 and 3 about here 
  
The results with respect to organizational capital also show significant differences 
between health care and other industries. This knowledge repository was not significantly 
associated with any element of IPE in the health care industry, but was positively associated with 
combinative capability and efficiency in other industries, providing support for Hypotheses 2a 
and 2b in the non-health care industries but not in the health care industry. I also find support for 
Hypothesis 2c in non-health care industries. Both combinative capability and efficiency were 
positively related to output quality, mediating the relationship between organizational capital and 
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output quality. Again, results of the all-industries model (model 3) mirrored those for model 2. 
No mediating relationship was found in the health care industry as organizational capital had no 
relationship to any element of IPE. Given the absence of an effect for organizational capital and 
a positive effect of human capital in the health care industry, Hypothesis 3 was supported; human 
capital did have a stronger relationship to IPE than organizational capital in this industry. 
 As shown in Table 4, the mediation tests confirmed my SEM results and provided further 
clarity about the effects. In the health care industry, the relationship between human capital and 
output quality was only mediated by combinative capability (BCB CI95%= 0.001-0.489). 
Efficiency did not mediate (CI95% = -0.023-0.234) and no effect of organizational capital on IPE 
was found. In other industries, however, both combinative capability and efficiency mediated 
between human capital and output quality (CI95% = 0.082-0.362 and CI95% = 0.012-0.209, 
respectively) and between organizational capital and output quality (CI95% = 0.109-0.296 and 
CI95% = 0.013- 0.154, respectively). Contrast tests showed both variables to be equally strong 
mediators of the human capital-output quality relationship (CI95%Contrast = -0.010-0.310), and 
combinative capability to be a significantly stronger mediator of the organizational capital-output 
quality relationship than efficiency (CI95%Contrast = 0.019-0.258). Across all models, the control 
variables of firm age, R&D emphasis, past performance, industry type, and home country were 
not significant (p > 0.10). 
Please insert Table 4 about here 
 
5. DISCUSSION 
The purpose of this research was to advance the understanding of IPE, an important yet little 
understood determinant of successful innovation. I proposed and my results confirmed that 
organizations’ access to knowledge repositories plays a key role in contributing to greater IPE. 
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Recent research has highlighted the importance of knowledge repositories for organizational 
effectiveness and innovation outcomes (Menor et al. 2007), but the connection to IPE had not 
been proposed and investigated. My results show not only which knowledge repositories (i.e., 
human and/or organizational capital) are significant for IPE in different industries but also the 
pathway by which individual repositories affect each element of IPE and the relationship 
between elements (combinative capability, process efficiency, and output quality).  
In sum, my results suggest that human capital affects output quality through combinative 
capability in the health care industry, while human and organizational capital affect output 
quality through two pathways – combinative capability and efficiency – in other innovative 
industries. I also found that human capital in the health care industry (R2= 0.656) has a similar 
magnitude of effect on output quality as the combination of human and organizational capital in 
other industries (R2 = 0.664). These findings reinforce the importance of human capital in health 
care and also indicate that human capital is necessary but not sufficient for IPE in other 
innovative industries. Organizational capital may also be needed in other innovative industries 
because external, collective repositories are not as dominant in other industries. In health care, 
such external repositories play a central role. For example, on the health care delivery side, 
professional associations and government databases exist for this purpose, while on the health 
care supplier side, knowledge, particularly about the innovation process, is highly informed and 
regulated by government agencies. Thus, individuals in health care first and foremost carry 
professional-based knowledge (e.g., knowledge of surgical procedures) (Huckman and Pisano 
2006). In other industries workers often carry as much organization-based knowledge (e.g., 
knowledge of development processes), hence the documented loss of organizations’ capabilities 
when workers depart and recommendations to invest in organizational capital to prevent erosion 
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of organizational knowledge (Huber 1991). 
Although I predicted the effect of organizational capital to be weaker in health care due 
to industry-related knowledge properties, the insignificant effect was surprising. Despite this 
result, I caution against assuming that access to this repository is not beneficial for IPE in health 
care. Recent research shows that checklists, a form of organizational capital, can be helpful for 
the implementation of innovations but also suggests that gains from their use depends on 
professional support for this tool (Gawande 2010) . Likewise, the effectiveness of organizational 
capital on IPE in health care may depend on other factors such as the perceived quality of the 
repository’s contents or unit culture. Future research should examine whether such factors 
moderate the effect of organizational capital on IPE in health care.   
The other surprising finding was that the relationship between IPE dimensions also 
differed in the health care industry. Efficiency did not predict perceived output quality in this 
industry, as it did in other innovative industries. The disconnect in health care suggests the need 
for revision in the conceptualization of IPE. My hypotheses had implicitly suggested two stages 
of IPE with combinative capability and efficiency in the first stage, resulting in output quality in 
the second stage. While results for non-health care industries support that conceptualization, 
results for the health care industry indicate an alternative formulation with two elements of 
effectiveness in the second stage i.e., efficiency and output quality, with the latter resulting from 
combinative capability in the first stage. That efficiency is not a consideration in valuation of 
output quality may reflect that the innovation timeline is heavily regulated for suppliers limiting 
their influence on efficiency, and may also reflect that a process that results in life-saving output 
is valued even if inefficient. Thus, the two dimensions of IPE can be unrelated in health care. 
The goal of this research was to offer insight on IPE, but it also adds to research on 
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knowledge repositories, specifically to research that considers the effects of individual 
repositories as opposed to repositories as a whole (e.g., Menor et al. (2007)). Thus far, studies of 
individual repositories have shown that different repositories can affect different outcomes and 
affect the same outcome differently. For example, Subramaniam and Youndt (2005) showed that 
organizational capital positively influences incremental innovative capability, while human 
capital negatively influences radical innovative capability in the absence of countervailing 
forces. This work extends this research by showing that different repositories can not only affect 
the same outcome through different processes but also have varying effects across industries.  
  Taken together, my results also inform the debate about whether health care is different. 
In many respects health care mirrors other industries. For example, it relies on knowledge 
workers similar to other professional service or scientific manufacturing industries; it has a 
professional hierarchy like many labor-intensive ones; and it faces cost-cutting pressures like 
most industries. Nevertheless, my IPE findings indicate that health care differs from other 
innovative industries. From a research and theory development standpoint, this difference is 
significant. It affirms the importance of considering contextual specificity. There have been 
several calls for more context-mindful, industry-specific research across scholarly fields from 
organizational behavior (Tamuz and Thomas 2006) to production and operations management 
(Beckman and Sinha 2005). Yet, research has responded slowly perhaps because of a focus on 
generalizable research. My results suggest the importance of industry studies to advance 
understanding of dynamics within industries and to be helpful to specific industries. Failure not 
to consider industry-specific dynamics raises the risk of developing theory and recommendations 
that are incorrect for some. 
This thesis' results imply that investing in all knowledge repositories is not the most 
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effective approach for optimizing IPE in all industries. Organizations and their managers are 
better served by identifying repositories specifically linked to IPE in their industry and 
selectively investing in them. Based on my results, managers in health care should invest in 
human capital to increase their organization’s IPE, while managers in other innovative industries 
should focus on developing human and organizational capital. Prior work suggests that employee 
selection, training, and rewards are effective tools that managers can use to develop human 
capital (Huselid and Becker 2011), whereas investments in information technology can enhance 
organizational capital (Poston and Speier 2005). Whether there are other tools that are 
particularly effective for developing each form of capital remains a question to be explored. 
Additionally, for industries that require both human and organizational capital, there remains a 
question about how to effectively combine tools to foster the development of these important 
knowledge repositories. For all organizations, my results point to the importance of tools 
supporting human capital and thus worker development. To realize the benefits of that 
investment, organizations must attend as much to retention and development of skilled workers 
as to their recruitment. Retention has been a challenge for managers in health care delivery 
(Waldman et al. 2004), an environment where quality and safety are paramount and turnover has 
especially negative consequences, as a recent meta-analysis showed (Hancock et al. 2013). 
Health care suppliers have also cut 300,000 jobs over the past ten years, equivalent to the size of 
the top three firms in the industry (Herper 2011). My results imply that there is value in 
managers' continued pursuit of retaining and developing skilled workers. 
As with most research, this study has limitations. First, the cross-sectional nature of my 
data prevents me from concluding that access to knowledge repositories determines IPE; another 
variable correlated with both access to knowledge repositories and IPE may explain my results. 
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Second, my sample only included organizations in the US and UK and only those that satisfied 
my size and innovativeness thresholds. The limited sample leaves open the question of whether 
the presented results generalize to organizations in other cultural clusters and with different sizes 
and innovativeness. Third, although my survey response rate is similar to that of other innovation 
and key informant studies, the low rate raises the possibility that my results reflect non-response 
bias. However, when I assessed this bias using Armstrong and Overton's (1977) procedure of 
comparing early and late respondents, I found no significant difference minimizing concerns 
about non-response bias. Fourth, I collected data regarding knowledge repositories and IPE from 
a single key informant, which raises the possibility of common method bias. I conducted two 
post-hoc tests to assess the likelihood of such bias. The first, Harman's one-factor test, showed 
multiple factors emerging in factor analysis and none were dominant. The second test, including 
a common method factor into my model (Podsakoff et al. 2003), showed  that method-based 
variance was 0.01, miniscule compared to variance explained by the constructs of 0.75. While 
these tests do not eliminate the possibility of common method bias, they provide evidence that 
my results are not driven by such bias. Last, the relatively small health care sample (N=73) might 
raise questions about whether the non-significant results for organizational capital might be due 
to statistical limitations. Given that I found significant results for human capital in this small 
sample, statistical limitations do not seem to have prevented detection of significant effects and 
true differences for health care. 
A next step for research is to investigate the role that other knowledge repositories such 
as social capital – knowledge embedded within and utilized by interactions among individuals – 
may play for IPE in health care and other industries. I chose to focus on human and 
organizational capital because they are widely accepted as fundamental repositories and 
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managers readily exercise influence over them.  
  In conclusion, this thesis provides evidence for the importance of knowledge repositories 
for IPE and documents the contextual specificity of this relationship. This insight is a step in the 
direction of better understanding the relationship between knowledge and innovation and 
showing the impact of industry effects. Based on my findings, researchers may be well-served by 
incorporating industry-specific dynamics into their theorizing. Unless potential variance across 
industries is taken into consideration, wholehearted recommendations based on aggregate results 
may be misdirected because of the risk associated with investing in knowledge processes and its 
demanding resource requirements. I hope that this study inspires more research that is conscious 
of industry dynamics and their role in innovation and other knowledge-based processes.   
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Table 1 Response Demographics
Industry type NAICS affiliation UK US Respondent profile
Health care Tenure (years) UK US
Suppliers: Pharma/ Chemicals; Medical instruments 325/ 339 29% 22% >20 63% 91%
Delivery: Health care organizations (e.g. hospitals) 54, 62 8% 7% 11-20y 27% 6%
6-10y 4% 2%
Other innovative industries 3-5y 4% 0%
Computer/ Electronic 334-335 15% 10% <3y 2% 1%
Specialized machinery 31, 33 12% 11%
Financial servicesᵃ 52 18% 32% Position UK US
Telecommunicationsᵃ 51 8% 14% Top management 88% 89%
Professional servicesᵇ 54 4% 1% Middle managemt 10% 9%
Scientific servicesᵇ 54 6% 3% Line management 2% 2%
Firm size (number of employees) UK US Degree of strategic involvement UK US
10-49 4% 5% Very high 72% 70%
50-99 15% 17% High 14% 19%
100-249 14% 23% Moderate 7% 6%
250-999 27% 19% Low 7% 3%
1000-2499 10% 13% Very low 0% 2%
2500-9999 15% 7% UK (N=114); US (N=107)
>10000 15% 16%
UK (N=110); US (N=100): Excluding private equity firms who reported employees based on firm portfolio
Note: Innovative industry classification adapted from Castellacci (2008) 
ᵃ Network-infrastructure services; ᵇ Knowledge–intensive services
NAICS (North American Industry Classification Systems), mapped to NACE for UK firms (NACE is the statist ical classification of economic activit ies in the European community) 
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Table 2 Correlations, Means, and Standard Deviations
Latent variable 1. 2. 3. 4. 5.
1. Human capital (HC) 1.00 0.37** 0.46*** 0.43*** 0.54***
2. Organizational capital (OC) 0.29* 1.00 0.25* 0.25* 0.25*
3. Combinative capability (CC) 0.42*** 0.39*** 1.00 0.62*** 0.76***
4. Process efficiency (PE) 0.44*** 0.39*** 0.54*** 1.00 0.58***
5. Output quality (OQ) 0.39*** 0.41*** 0.78*** 0.57*** 1.00
Notes: Pearson correlation; Health care sample above the diagonal; Non-health care sample below the diagonal
*** Significance at p  < 0.001; ** p  < 0.01; * p  < 0.05 (two-tailed)
Health care (N=73)
Mean 5.69 5.01 5.31 4.95 5.19
Standard deviation 0.92 1.08 0.95 1.16 0.94
Non-health care (N=148)
Mean 5.50 4.16 5.09 4.75 4.93
Standard deviation 0.94 1.30 1.18 1.34 1.28
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Table 3 Path Estimates, R²
Model 1. 2. 3.
Path
Health care 
Path coefficients
Non-health care
Path coefficients
Full sample
Path coefficients
Human capital → Combinative capability 0.415** 0.323*** 0.342***
Human capital → Process efficiency 0.387* 0.359*** 0.364***
Human capital → Output quality 0.216* 0.003 0.055
Organizational capital → Combinative capability 0.119 0.311*** 0.266***
Organizational capital → Process efficiency 0.129 0.280*** 0.243***
Organizational capital → Output quality 0.001 0.061 0.079
Combinative capability → Ouput quality 0.584*** 0.577*** 0.594***
Process efficiency → Ouput quality 0.208 0.210* 0.186**
R² Combinative capability 0.232 0.267 0.256
R² Process efficiency 0.213 0.273 0.256
R² Ouput quality 0.656 0.664 0.649
Notes: Controlling for (1) firm age, (2) innovation emphasis, (3) past performance, (4) industry type, (5) home country; (all not statistically significant, p  > 0.10)
*** Significance at p  < 0.001; ** p  < 0.01; * p  < 0.05. Health care sample (N = 73); Non-health care sample (N = 148); Full sample (N = 221)                  
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Table 4. Mediation analysis of the effect of knowledge repositories on innovation process output quality through combinative capability and efficiency 
Health care–IPE output quality Non–health care–IPE output quality
Antecedents Mediators Point Estimate 95% CI (PB) 95% CI (BCB) Point Estimate 95% CI (PB) 95% CI (BCB)
Human Capital (HC) Combinative Capability (CC) 0.237* [0.054;0.557] [0.001;0.489] 0.203* [0.067;0.338] [0.082;0.362]
Efficiency (EF) 0.058 [-0.027;0.221] [-0.023;0.234] 0.074* [0.004;0.185] [0.012;0.209]
Total Indirect Effect (CC+EF) 0.295 [0.086;0.644] [-0.034;0.564] 0.277* [0.134;0.432] [0.135;0.435]
Contrast (CC-EF) 0.180 [-0.013;0.526] [-0.066;0.490] 0.129 [-0.034;0.285] [-0.010;0.310]
Organizational Capital (OC) Combinative Capability (CC) 0.054 [-0.106;0.211] [-0.095;0.230] 0.194* [0.106;0.288] [0.109;0.296]
Efficiency (EF) 0.020 [-0.023;0.081] [-0.005;0.119] 0.057* [0.006;0.130] [0.013;0.154]
Total Indirect Effect (CC+EF) 0.074 [-0.115;0.253] [-0.097;0.278] 0.251* [0.147;0.367] [0.158;0.379]
Contrast (CC-EF) 0.034 [-0.113;0.193] [-0.095;0.214] 0.137* [0.020;0.258] [0.019;0.258]
Notes: * Significance at p  < 0.05; CI (Confidence Interval); PB (Percentile Bootstrap); BCB (Bias-Corrected Bootstrap)
Health care sample (N = 73); Non-health care sample (N = 148)             
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Appendix A: Survey measures with psychometric properties
Human capital: Range 'strongly disagree ' to 'strongly agree ' (Subramaniam & Youndt 2005) Factor Loadings
To what extent do you agree with the following items describing your organization's human capital:
HC1 Our employees are highly skilled 0.83
HC2 Our employees are widely considered the best in our industry 0.81
HC3 Our employees are creative and bright 0.87
HC4 Our employees are experts in their particular jobs and functions 0.76
HC5 Our employees develop new ideas and knowledge 0.86
Cronbach's alpha (α) 0.89
Composite reliability (CR) 0.92
Average variance extracted (AVE) 0.69
Square root (AVE) 0.83
Organizational capital: Range 'strongly disagree ' to 'strongly agree ' (Subramaniam & Youndt 2005)
To what extent do you agree with the following items describing your organization's organization capital:
OC1 Our organization uses patents and licenses as a way to store knowledge 0.66
OC2 Much of our organization’s knowledge is contained in manuals, databases, etc. 0.80
OC3 Our organization’s culture (stories, rituals) contains valuable ideas, ways of doing business, etc. -
OC4 Our organization embeds much of its knowledge and information in structures, systems, and processes 0.76
Cronbach's alpha (α) 0.60
Composite reliability (CR) 0.79
Average variance extracted (AVE) 0.55
Square root (AVE) 0.74
Combinative capability: Range 'strongly disagree ' to 'strongly agree ' (adapted from Brettel et al. 2012)
The innovation process meets objectives and expectations in terms of the …
CC1 Learnings and expertise that can be leveraged in future endeavors 0.93
CC2 Generation of new ideas as starting point of potential future endeavors 0.91
CC3 Enhancement of competencies and capabilities 0.92
Cronbach's alpha (α) 0.91
Composite reliability (CR) 0.94
Average variance extracted (AVE) 0.84
Square root (AVE) 0.92
Process efficiency: Range 'strongly disagree ' to 'strongly agree ' (adapted from Brettel et al. 2012)
The innovation process meets objectives and expectations in terms of …
PE1 Meeting schedules 0.92
PE2 Staying on budget 0.84
PE3 Meeting operational and technical performance of the organizational expectations on innovation 0.92
Cronbach's alpha (α) 0.87
Composite reliability (CR) 0.92
Average variance extracted (AVE) 0.80
Square root (AVE) 0.89
Output quality: Range 'strongly disagree ' to 'strongly agree ' (adapted from Brettel et al. 2012)
The innovation process meets objectives and expectations in terms of the …
OQ1 Perceived value of the innovation output 0.93
OQ2 Opportunities to market innovation output 0.92
OQ3 Quality and performance of the innovation output 0.93
Cronbach's alpha (α) 0.92
Composite reliability (CR) 0.95
Average variance extracted (AVE) 0.86
Square root (AVE) 0.93
(-) Item dropped as result of principal components factor analysis
